When the Food and Drug Administration approved Gleevec to treat a form of leukemia in 2001, it ushered in a new era in cancer ...

A team of researchers led by NYU Tandon School of Engineering's Weiqiang Chen has developed a miniature device that could transform how blood cancer treatments are tested and tailored for patients.

Developing effective immunotherapies for acute myeloid leukemia (AML) has long been hampered by a critical challenge: Therapy directed at killing the leukemia cells may also harm the body's ability to ...

A Central Illinois woman is dedicating her life helping others fight cancer — and she’s doing it by raising money to give ...

September is Leukemia and Lymphoma Awareness Month. An estimated 1,629,474 people in the United States (US) are living with or in remission from leukemia, lymphoma, myeloma, myelodysplastic syndromes ...

Scientists from the German Cancer Research Center (DKFZ) and the HI-STEM Stem Cell Institute have deciphered a key mechanism ...

CHARLESTON, S.C. (WCIV) — MUSC researchers at the Hollings Cancer center are making strides in new developments for leukemia treatment. Sophie Paczesny, M.D., Ph.D., the principal investigator for ...

A new study confirmed an elevated risk for myelodysplastic syndrome or acute myeloid leukemia (MDS/AML) after poly(ADP-ribose) polymerase (PARP) inhibitor therapy in women with ovarian cancer and ...

Scientists studying a hard-to-treat form of blood cancer called acute myeloid leukemia (AML) have found that a type of treatment - immunotherapy - may help change the environment where cancer cells ...

Acute lymphoblastic leukemia (ALL) and lymphoblastic lymphoma (LBL) are types of blood cancer. Acute lymphoblastic leukemia is a fast-growing type of blood cancer. It happens when the body makes too ...

"When you get cancer, nothing else matters," Danielle Eldridge says ...